Alzheimer’s Disease Associated Genes Ankyrin and Tau Cause Shortened Lifespan and Memory Loss in <i>Drosophila</i> by Higham, James et al.
                          Higham, J., Malik, B. R., Buhl, E., Dawson, J., Ogier, A. S., Lunnon, K., &
Hodge, J. (2019). Alzheimer’s Disease Associated Genes Ankyrin and Tau
Cause Shortened Lifespan and Memory Loss in Drosophila. Frontiers in
Cellular Neuroscience, 13, [260]. https://doi.org/10.3389/fncel.2019.00260
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.3389/fncel.2019.00260
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Frontiers at
https://www.frontiersin.org/articles/10.3389/fncel.2019.00260/full . Please refer to any applicable terms of use of
the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
fncel-13-00260 June 11, 2019 Time: 15:43 # 1
ORIGINAL RESEARCH
published: 11 June 2019
doi: 10.3389/fncel.2019.00260
Edited by:
Miguel Medina,
Network Biomedical Research Center
on Neurodegenerative Diseases
(CIBERNED), Spain
Reviewed by:
Kunie Ando,
Free University of Brussels, Belgium
Efthimios M. C. Skoulakis,
Alexander Fleming Biomedical
Sciences Research Center, Greece
*Correspondence:
James J. L. Hodge
james.hodge@bristol.ac.uk
†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Cellular Neuropathology,
a section of the journal
Frontiers in Cellular Neuroscience
Received: 01 February 2019
Accepted: 23 May 2019
Published: 11 June 2019
Citation:
Higham JP, Malik BR, Buhl E,
Dawson JM, Ogier AS, Lunnon K and
Hodge JJL (2019) Alzheimer’s
Disease Associated Genes Ankyrin
and Tau Cause Shortened Lifespan
and Memory Loss in Drosophila.
Front. Cell. Neurosci. 13:260.
doi: 10.3389/fncel.2019.00260
Alzheimer’s Disease Associated
Genes Ankyrin and Tau Cause
Shortened Lifespan and Memory
Loss in Drosophila
James P. Higham1†, Bilal R. Malik1†, Edgar Buhl1, Jennifer M. Dawson1, Anna S. Ogier1,
Katie Lunnon2 and James J. L. Hodge1*
1 School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom, 2 University of Exeter
Medical School, University of Exeter, Exeter, United Kingdom
Alzheimer’s disease (AD) is the most common form of dementia and is characterized
by intracellular neurofibrillary tangles of hyperphosphorylated Tau, including the 0N4R
isoform and accumulation of extracellular amyloid beta (Aβ) plaques. However, less
than 5% of AD cases are familial, with many additional risk factors contributing to
AD including aging, lifestyle, the environment and epigenetics. Recent epigenome-
wide association studies (EWAS) of AD have identified a number of loci that are
differentially methylated in the AD cortex. Indeed, hypermethylation and reduced
expression of the Ankyrin 1 (ANK1) gene in AD has been reported in the cortex
in numerous different post-mortem brain cohorts. Little is known about the normal
function of ANK1 in the healthy brain, nor the role it may play in AD. We have
generated Drosophila models to allow us to functionally characterize Drosophila Ank2,
the ortholog of human ANK1 and to determine its interaction with human Tau and
Aβ. We show expression of human Tau 0N4R or the oligomerizing Aβ 42 amino acid
peptide caused shortened lifespan, degeneration, disrupted movement, memory loss,
and decreased excitability of memory neurons with co-expression tending to make
the pathology worse. We find that Drosophila with reduced neuronal Ank2 expression
have shortened lifespan, reduced locomotion, reduced memory and reduced neuronal
excitability similar to flies overexpressing either human Tau 0N4R or Aβ42. Therefore,
we show that the mis-expression of Ank2 can drive disease relevant processes and
phenocopy some features of AD. Therefore, we propose targeting human ANK1 may
have therapeutic potential. This represents the first study to characterize an AD-relevant
gene nominated from EWAS.
Keywords: Alzheimer’s disease, Drosophila, memory, lifespan, locomotion, neurodegeneration, Tau, Ankyrin
INTRODUCTION
Alzheimer’s disease (AD) is the most common form of dementia, with patients suffering
from premature death and accelerated cognitive decline including memory loss. Post-mortem
examination of AD brain samples reveals the accumulation of extracellular amyloid-beta (Aβ)
plaques and intracellular neurofibrillary tangles (NFTs) of hyperphosphorylated microtubule
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associated protein Tau (MAPT), which is accompanied by gliosis,
neuronal cell loss, and brain atrophy. Aβ is produced by the
amyloidogenic cleavage of the amyloid precursor protein (APP)
by β and γ secretases resulting in the formation of neurotoxic
aggregating Aβ peptides with the 42 amino acid (aa) peptide
(Aβ42) being more toxic than Aβ40 (Selkoe and Hardy, 2016).
Tau exists in six different isoforms, which vary with the number
of N-terminal domains (0N, 1N or 2N) and the number of
C-terminal aggregating tubulin binding repeats (3R or 4R)
(Arendt et al., 2016). The 4R isoforms are upregulated in AD
brain and show stronger tubulin binding and aggregation than
the 3R isoforms (Arendt et al., 2016). Another contributing factor
to Tau aggregation is its hyperphosphorylation by a number of
different kinases including glycogen synthase kinase-3β, cyclin-
dependent kinase 5, JNK, microtubule-associated regulatory
kinase, DYRK1a and CaMKII (Hanger et al., 1992; Ferrer
et al., 2005; Plattner et al., 2006; Wang et al., 2007; Dolan
and Johnson, 2010; Ghosh and Giese, 2015). It is not currently
known how Aβ and Tau pathology are linked, however, the
amyloid cascade hypothesis suggests that Aβ pathology leads
to the other hallmarks of AD, including the spread of NFTs
(Selkoe and Hardy, 2016) and recent work suggests changes
in neuronal excitability and calcium (Ca2+) signaling may be
important for their connection and disease progression (Spires-
Jones and Hyman, 2014; Wu et al., 2016), but exactly how
remains unknown.
Less than 5% of AD cases are due to autosomal dominant
mutations in the APP, presenilin 1 (PSEN1) or PSEN2 genes. The
remainder of AD cases are sporadic, with incidence attributed
to both genetic and environmental risk factors. Genome-wide
association studies (GWAS) have identified a number of genes
where common genetic variation is associated with increased
risk of sporadic AD, including APOE (ε4 allele), BIN1 and
PICALM genes amongst others (Lambert et al., 2013) with many
additional risk factors for AD being associated with lifestyle
and/or the environment.
Epigenetics refers to the mitotically and meiotically heri-
table changes in gene expression without alterations in the
underlying DNA sequence for instance by DNA methylation
and downregulation of genes (Gräff and Sanchez-Mut, 2015).
This also potentially allows for alterations in gene expression
in response to environmental variation, such as stress, diet or
exposure to environmental chemicals. In order to characterize
the contribution of epigenetic mechanisms to AD etiology,
recent epigenome-wide association studies (EWAS) of AD have
been performed and have identified a number of genetic loci
that are associated with increased risk of AD (De Jager et al.,
2014; Lunnon et al., 2014; Smith et al., 2018). One locus that
showed consistent cortical AD-associated hypermethylation in
five independent cohorts resided in the Ankyrin 1 (ANK1)
gene (De Jager et al., 2014; Lunnon et al., 2014; Smith and
Lunnon, 2017). A recent publication has demonstrated that
ANK1 DNA methylation in the entorhinal cortex is observed
in only certain neurodegenerative diseases (Smith et al., 2019).
This study reported disease-associated hypermethylation in
AD, Huntington’s disease and to a lesser extent Parkinson’s
disease (PD). The authors showed that disease-associated
hypermethylation was only seen in donors with vascular
dementia (VaD) and dementia with Lewy bodies (DLB) when
individuals had co-existing AD pathology; in individuals with
“pure” VaD or DLB, no ANK1 hypermethylation was observed.
ANK1 is an integral membrane and adaptor protein, that
mediates the attachment of membrane proteins such as ion
channels, cell adhesion proteins and receptors with the spectrin-
actin cytoskeleton and is important for cell proliferation,
mobility, activation, and maintenance of specialized membrane
domains (Smith and Penzes, 2018).
Most of our understanding of the molecular changes that
cause AD pathology comes largely from experiments using
rodents to model genetic variation; however, these are models
of familial AD, and do not recapitulate sporadic disease. As
such, new drugs effective in these rodents have not translated
to any new successful treatments for AD highlighting the
need to generate and characterize new models of sporadic
AD (McGowan et al., 2006; Crews and Masliah, 2010; Van
Dam and De Deyn, 2011; Gama Sosa et al., 2012; Guo
et al., 2012; De Jager et al., 2014). In Drosophila, neuronal
overexpression of different human APP products (including
Aβ42) and mutants has been reported to cause degeneration
of the photoreceptor neurons of the fly eye, shortened lifespan,
change in neuronal excitability as well as movement, circadian,
sleep, and learning defects in a number of different studies
(Iijima et al., 2004; Chiang et al., 2010; Speretta et al., 2012;
Chen et al., 2014; Blake et al., 2015; Ping et al., 2015; Tabuchi
et al., 2015). Likewise, neuronal overexpression of human Tau
isoforms associated with AD have been shown to result in
degeneration of the photoreceptor neurons of the fly eye,
shortened lifespan, movement and learning defects in many
different studies (Wittmann et al., 2001; Folwell et al., 2010;
Iijima-Ando and Iijima, 2010; Kosmidis et al., 2010; Beharry et al.,
2013; Papanikolopoulou and Skoulakis, 2015; Sealey et al., 2017).
Fewer animal models have determined the effect of expression
of human Aβ and Tau quantifying the effect on lifespan, axonal
transport, synaptic morphology, degeneration of the eye and
climbing (Folwell et al., 2010; Iijima et al., 2010; Lee et al.,
2012; Shulman et al., 2014). Co-expression more accurately
reflects the progression of AD in humans (Guerreiro and Hardy,
2011; Selkoe, 2012; Spires-Jones and Hyman, 2014; Bouleau and
Tricoire, 2015; Arendt et al., 2016; Selkoe and Hardy, 2016).
Furthermore, fewer studies have compared the effect of common
variants nominated from GWAS for AD (Shulman et al., 2011,
2014; Gotz et al., 2012; Chapuis et al., 2013; Dourlen et al.,
2016) and to our knowledge none from EWAS for AD. Thus,
many genomic and epigenomic loci nominated in these studies
remain uncharacterized in any living organism, with many of
these genes or loci having a completely unknown function in
the brain (Guerreiro and Hardy, 2011; Shulman et al., 2011;
Gotz et al., 2012; De Jager et al., 2014; Del-Aguila et al., 2015;
Devall et al., 2016).
In order to address these issues, we have characterized
the first animal model to investigate the function of a locus
nominated from EWAS in AD. We have investigated ANK
mis-expression and compared its AD relevant phenotypes to
Drosophila models expressing either (a) human mutant APP
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(which results in an aggregating form of oligomerized Aβ42),
(b) MAPT (resulting in 0N4R Tau), (c) APP (Aβ42) with
MAPT (0N4R Tau), and (d) APP (Aβ42) or MAPT (0N4R
Tau) with Ank mis-expression, finding that mis-expression of
these AD associated genes cause similar reduction in lifespan,
movement, memory and neuronal excitability. We also report
for the first time the effect of human Aβ42, 0N4R Tau and co-
expression on 1 h memory and determine how Aβ42 and 0N4R
Tau change mushroom body (MB) memory neuron excitability
prior to neurodegeneration.
MATERIALS AND METHODS
Drosophila Genetics
Flies were raised at a standard density with a 12 h:12 h light
dark (LD) cycle with lights on at ZT 0 (Zeitgeber time) on
standard Drosophila medium (0.7% agar, 1.0% soya flour, 8.0%
polenta/maize, 1.8% yeast, 8.0% malt extract, 4.0% molasses,
0.8% propionic acid, and 2.3% nipagen) at 25◦C. The following
flies used in this study were previously described or obtained
from the Bloomington and Vienna fly stock centers: wild type
control was Canton S w- (CSw-) (gift from Dr. Scott Waddell,
University of Oxford). Experimental genotypes were elav-Gal4
(Bloomington stock center line number BL8760), OK107-Gal4
(BL854), GMR-Gal4 (BL9146), uas-human MAPT (TAU 0N4R)
wild type (gift from Dr. Linda Partridge, University College
London) (Wittmann et al., 2001; Kerr et al., 2011), uas-human
tandem Aβ42-22 amino acid linker-Aβ42 (gift from Dr. Damian
Crowther, University of Cambridge) (Speretta et al., 2012),
uas-GFP (gift from Dr. Mark Wu, Johns Hopkins University),
uas-GCaMP6f [BL42747 (Shaw et al., 2018)], uas-Ank2-RNAi
line A (BL29438), uas-Ank2 RNAi (Vienna Drosophila RNAi
Center stock number VDRC107238 and KK10497) and uas-
Ank2 (gift from Dr. Ron R. Dubreuil, University of Illinois)
(Mazock et al., 2010).
Survival Assay
Approximately 2 days after eclosion 10 mated females were
transferred to a vial containing standard food and maintained
at 25◦C throughout. Deaths were scored every 2 days and
then transferred to a fresh food vial (Kerr et al., 2011). Data
was presented as Kaplan–Meier survival curves with statistical
analysis performed using log-rank tests to compare survival
between genotypes. All statistical tests were performed using
Prism (GraphPad Software Inc., La Jolla, CA, United States).
Eye Degeneration Assay
Two to five day old adult flies were anesthetized by CO2 prior
to immersion in ethanol in order to euthanize the fly to prevent
any further movement during image capture (Folwell et al., 2010).
The eyes were imaged with a Zeiss AxioCam MRm camera
attached to a stereomicroscope (Zeiss SteREO Discovery.V8, up
to 8×magnification). Surface area was quantified using Zeiss Zen
software and normalized to the mean size of the wild type control.
One-way ANOVA with Dunnett’s multiple comparisons was used
to analyze data.
Climbing Assay
Ten 2–5 day old flies were collected and given 1 h to acclimatize to
the test vial in an environmentally controlled room at 25◦C and
70% humidity. Using the negative geotaxis reflex of Drosophila,
flies were gently tapped to the bottom of a 7.5 cm plastic vial and
the number of flies that crossed a line drawn 2 cm from the top of
the tube in 10 s was counted, and then expressed as a % which was
referred to as the climbing performance or climbing index (Iijima
et al., 2004; Sun et al., 2018). One-way ANOVA with Dunnett’s
multiple comparisons was used to analyze data.
Memory
One hour memory and sensory controls were performed
as previously described using the olfactory-shock aversive
conditioning assay (Cavaliere et al., 2013; Malik et al., 2013; Malik
and Hodge, 2014). Experiments were performed with groups of
30–50 flies aged between 2 and 5 days old of a given genotype,
in a T-maze apparatus housed in an environmentally controlled
room at 25◦C and 70% humidity under dim red light. Flies were
exposed to either 4-methylcyclohexanol (MCH, Sigma, ∼1:200)
or 3-octanol (OCT, Sigma,∼1:100) diluted in mineral oil (Sigma)
paired with 1.5 s pulses of 60 V electric shock interspersed with
3.5 s pauses from shock for a minute. After 30 s of fresh air
the flies were exposed to the reciprocal order without shock
for another minute. After a 1 h rest, memory was assessed by
transferring the flies to a choice point of the T maze, with one arm
containing the shock paired odor and the other the non-shock
paired odor, flies showed learning by avoiding the shock paired
odor (i.e., correct flies).
Performance index (PI)
= (number of correct flies − number of incorrect flies)/
total number of flies
To eliminate odor bias, the assay was performed with two groups
of flies (30–50 flies in each), one shocked with MCH and then
the other shocked with OCT. The average of the two groups
was taken to give an n = 1 PI value. Control experiments were
performed to show that the different genotypes of flies could
respond to MCH, OCT and shock alone. One-way ANOVA with
Dunnett’s multiple comparisons was used to analyze data.
Calcium Imaging and Microscopy
Calcium imaging and imaging of the MB structure was performed
using a genetically encoded GCaMP Ca2+ reporter and adapting
previously published protocols (Cavaliere et al., 2012; Gillespie
and Hodge, 2013; Malik et al., 2013; Schlichting et al., 2016;
Shaw et al., 2018). Adult flies of the indicated genotypes using
OK107-Gal4 and uas-GCaMP6f were collected between 2 and
5 days post-eclosion, decapitated and the brain dissected in
extracellular saline solution containing (in mM): 101 NaCl, 1
CaCl2, 4 MgCl2, 3 KCl, 5 glucose, 1.25 NaH2PO4, 20.7 NaHCO3,
pH adjusted to 7.2. Brains were placed ventral side up in the
recording chamber, secured with a custom-made anchor and
continuously perfused with aerated saline. Images of the whole
MB of each genotype was captured in the resting state. To activate
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FIGURE 1 | The effect of expression of human mutant APP (Aβ42), MAPT (Tau 0N4R) and Drosophila Ank2 on Drosophila lifespan. (A) Survival curves of
pan-neuronal expressing Aβ42 (elav > Aβ42), Tau (elav > Tau), Ank2-RNAi (elav > Ank2-RNAi line A or B), Ank2 (elav > Ank2), (B) Tau with Aβ42 (elav > Tau, Aβ42),
Aβ42 with Ank2-RNAi (elav > Aβ42, Ank2-RNAi line A or B), Aβ42 with Ank2 (elav > Aβ42, Ank2), Aβ42 with Ank2 (elav > Aβ42, Ank2), Aβ42 with Ank2
(elav > Aβ42, GFP), Tau with Ank2-RNAi (elav > Tau, Ank2-RNAi line A or B), Tau with Ank2 (elav > Tau, Ank2), Tau with GFP (elav > Aβ42, GFP) compared to wild
type control (elav/+) flies kept at 25◦C. Misexpression of all Alzheimer’s disease (AD) genes caused a significant reduction in lifespan compared to control using the
Kaplan–Meier and log rank test (n > 100 per genotype of flies). (C) Table listing all genotypes characterized with median lifespan (days) and significant reductions in
lifespan as determined by Kaplan–Meier and log rank test and indicated as ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 and used in all subsequent figures.
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neurons, high concentration KCl (100 mM in saline) was bath
applied through the perfusion system for 4 min and then washed
out. The calcium fluorescence signal was acquired using a CCD
camera (Zeiss Axiocam) and a 470 nm LED light source (Colibri,
Zeiss) on an upright Zeiss Examiner microscope with a 20×water
immersion lens, recorded with ZEN (Zeiss, 4 frames/sec) and
plotted with Microsoft Excel. One-way ANOVA with Dunnett’s
multiple comparisons was used to analyze data.
RESULTS
Mis-Expression of Human Mutant APP,
MAPT or Ank2 Shortens Lifespan
Increased neuronal levels of Aβ or Tau lead to AD pathology
and early death (Selkoe, 2012; Selkoe and Hardy, 2016). We
therefore overexpressed in all neurons either an aggregating
form of human mutant APP that encodes oligomerized human
Aβ42 [tandem Aβ42 (Speretta et al., 2012)] or human MAPT
[0N4R Tau (Papanikolopoulou and Skoulakis, 2015; Sealey et al.,
2017)] both of which caused premature death reducing the
flies’ lifespan by about 25% (Figures 1A,C). In order to test
for a genetic interaction between the two neurotoxic genes,
we overexpressed both mutant APP (Aβ42) and MAPT (0N4R)
together in all neurons and got a further reduction to exactly
half the lifespan of a normal fly. The reduction in median
lifespan due to co-expression was equivalent to an additive
effect of the shortening of life due to mutant APP (Aβ42)
and MAPT (0N4R) alone, this suggests that Aβ42 and Tau
pathology may act in separate pathways to cause neurotoxicity
and early death.
Recently, human ANK1 gene has been shown to be
differentially methylated in AD (Lunnon et al., 2014). There
are two other ANK genes in the human genome, ANK2, and
ANK3. In Drosophila, there are two Ank genes, the ubiquitously
expressed Ank1, and neuron specific Ank2 (Koch et al., 2008;
Pielage et al., 2008; Mazock et al., 2010; Keller et al., 2011;
Siegenthaler et al., 2015). The closest ortholog to Drosophila
Ank1 is human ANK3 with 51% total amino acid identity while
the closest ortholog of Drosophila Ank2 is human ANK1 with
43% amino acid identity. Human ANK2 is more similar to
Drosophila Ank1 (49% identity) than Drosophila Ank2 (33%
identity). Because hypermethylation of human ANK1 has been
reported in AD cortex (Lunnon et al., 2014), we used RNAi
to knock-down expression of Ank1 and Ank2 comparing the
effect of reducing these genes in all Drosophila neurons using
two different RNAi transgenes designed to non-overlapping
regions of each gene. Pan-neural reduction in expression of
Drosophila Ank1 did not cause any AD relevant behavioral
deficits (Figures 2A,B), while reduction in Ank2 using the same
promoter and assay did cause a reduction in 1 h memory
(Figure 2B). Therefore, we conclude, that Drosophila Ank2 is
the closest functional ortholog of human ANK1, which we
characterized in subsequent experiments.
We found that pan-neural reduction of Ank2 resulted
in a shortening of lifespan by 15% compared to control
(Figures 1B,C). We verified our results by using two independent
FIGURE 2 | The effect of pan-neuronal expression of Drosophila Ank1 and
Ank2 on behavior. (A) The negative geotaxis-climbing reflex was used to
quantify motor deficits of 2–5 day old flies. Pan-neuronal reduction of Ank1
(elav-Gal4 > Ank1-RNAi line A or B) was compared to control using one-way
ANOVA with Dunnett’s multiple comparison and showed no significant
difference. n ≥ 6 groups of 10 flies. (B) One hour memory of 2–5 day old flies
was assessed using the olfactory shock-conditioning assay. Pan-neuronal
reduction in Ank2 (elav > Ank2-RNAi line A) as opposed to Ank1
(elav > Ank1-RNAi line A) caused a significant reduction in memory compared
to control using one-way ANOVA with Dunnett’s multiple comparisons. Error
bars are standard error of the mean (SEM). n ≥ 4 groups of ∼50 flies.
RNAi lines (A and B) to non-overlapping sequences in Ank2,
both lines gave similar results in all assays. Depending on
the genomic location of DNA methylation, it can result in
either increased or decreased expression of the target gene
(Suzuki and Bird, 2008); we therefore tested if neuronal Ank2
overexpression affected longevity and found that it also shortened
lifespan (∼10%), but at a lower significance level to all other
genotypes. In order to test if there was a genetic interaction
between mutant APP (Aβ42) or MAPT (0N4R) and Ank2 we
generated flies that co-expressed mutant APP (Aβ42) or MAPT
(0N4R) with the Ank2 transgenes. We found that the detrimental
effect of each gene on lifespan remained (Figures 1B,C),
suggesting changing the level of fly Ank2 could not rescue
the shortened lifespan caused by overexpression of human
mutant APP (Aβ42) or MAPT (0N4R) to a level similar to
wild type control (elav/+). One potential cause of a reduction
or suppression of toxicity of a gene product is dilution of
Gal4. This is due to a single Gal4 transcription factor driving
expression by binding to a single UAS transgene [e.g., mutant
APP (Aβ42) or MAPT (0N4R)] which may get diluted when
adding a second UAS site of a gene (e.g., Ank2). This results
in a reduction in the amount of the AD toxic gene product
being made, giving a false positive of a suppression phenotype.
To control for such a dilution effect, we generated flies that
co-expressed a second unrelated neutral gene product (GFP)
with either human mutant APP (Aβ42) or MAPT (0N4R
Tau). There was no significant change in neurotoxicity of the
mutant APP (Aβ42) or MAPT (0N4R Tau) when expressed
alone or with GFP.
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FIGURE 3 | The effect of expression of human mutant APP (Aβ42), MAPT (Tau 0N4R), and Drosophila Ank2 on degeneration of photoreceptor neurons. Images of
2–5 day old compound eyes of (A) control fly (GMR-Gal4/+) showing the regular alignment of ommatidia compared to photoreceptors neurons overexpressing,
(B) Aβ42 (GMR-Gal4 > Aβ42), (C) Tau (GMR-Gal4 > Tau), and (D) Tau with Aβ42 (GMR-Gal4 > Tau, Aβ42) which were smaller and displayed a “rough eye”
phenotype. (E,F) photoreceptors expressing Ank2-RNAi (GMR > Ank2-RNAi line A or B) or (G) Ank2 (GMR > Ank2) appeared normal. (H) Degeneration of
photoreceptor neurons was quantified as normalized percentage surface area of the eye of genotypes compared to the mean of the control (GMR/+) which was set
at 100%, comparisons were made between to mutant genotypes compared to control using one-way ANOVA with Dunnett’s multiple comparisons. Genotypes that
included expression of APP (Aβ42) or MAPT (Tau 0N4R) in the eye showed a significantly reduced size of eye, while those mis-expressing Drosophila Ank2 did not.
Co-expression of MAPT (Tau 0N4R) and Ank2 rescued eye size to a level indistinguishable from wild type. Error bars are SEM. n ≥ 7 eyes per genotype.
Overexpression of Human Mutant APP or
Mutant MAPT but Not Mis-Expression of
Ank2 Caused Degeneration of
Photoreceptor Neurons
Increased levels of aggregating toxic Aβ and Tau lead to
neurodegeneration and AD. In order to model this neurotoxicity
in Drosophila, human mutant APP causing Aβ42 production
(Figure 3B) or mutant MAPT (0N4R Tau) (Figure 3C)
was expressed throughout development and adulthood in the
photoreceptor neurons of the eye, resulting in a so called
“rough eye” phenotype, where the degeneration and loss of the
normally regularly arrayed ommatidia of the compound eye of
wild type flies (Figure 3A) gives rise to a disorganized and
smaller eye. The loss of photoreceptors could be quantified by
measuring the total surface area of the eye, which showed that
expression of human mutant APP (Aβ42) and MAPT (0N4R
Tau) reduced the size of the eye by 37% and 40%, respectively
(Figure 3H). Co-expression of human mutant APP (Aβ42)
and MAPT (0N4R Tau) (Figures 3D,H), resulted in a 53%
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reduction in eye size, suggesting that Aβ42 and Tau act in
partially overlapping pathways to cause neurotoxicity in the fly
eye. Reduction of Ank2 (Figures 3E,F), overexpression of Ank2
(Figure 3G) and co-expression of Ank2 and Tau did not cause
degeneration or reduction in size of the eye (Figure 3H), although
the latter cannot be considered a rescue as although the eye
was significantly larger (p < 0.01) than eyes expressing Tau it
was not significantly bigger than those expressing Tau and GFP
suggesting any suppression maybe due to a Gal4 dilution effect.
Overexpression of Human Mutant APP
and MAPT Genes and Reduction in Ank2
Expression Caused Locomotor Deficits
Flies exhibit a negative geotaxis reflex, such that after tapping
on a surface ∼80% of 2–5 day old wild type flies will climb to
the top of a tube in 10 s. This startle-induced reflex requires
the co-ordinated activity of dopaminergic neurons afferent to
the MB, and of MB Kenyon cells, in addition to MB efferent
neurons which communicate with central motor centers (Sun
et al., 2018). In order to quantify any detrimental effect of
human mutant APP (Aβ42) and MAPT (0N4R Tau) on this
behavior, we pan-neuronally (elav-Gal4 expressed humanmutant
APP (Aβ42) and MAPT (0N4R Tau), which resulted in a 20%
and 40% reduction in climbing ability, respectively. Likewise,
reduction in Ank2 expression caused a 15% reduction in
climbing, while Ank2 overexpression had no effect. All other gene
combinations were found to significantly reduce gross climbing
performance (Figure 4).
Overexpression of Human Mutant APP
and MAPT Genes and Reduced Ank2
Causes Memory Deficits
As multiple forms and phases of memory, including anterograde
memory, are affected by AD (Walsh and Selkoe, 2004), therefore
we measured the effect of the human mutant APP (Aβ42), MAPT
(0N4R Tau) and Drosophila Ank2 on memory. We performed
the olfactory shock assay on 2–5 day old flies (Cavaliere et al.,
2013; Malik et al., 2013; Malik and Hodge, 2014) assessing
associative memory at the 1 h time point, which is considered to
be intermediate memory in Drosophila. Olfactory shock memory
is mediated by MB neurons and we therefore drove expression of
the genes using a promoter (OK107-Gal4) with broad expression
in these neurons (Cavaliere et al., 2013; Malik et al., 2013). We
found MB expression of human mutant APP (Aβ42) or MAPT
(0N4R Tau) caused a large reduction in memory (Figure 5).
Ank2 is highly expressed in the adult MB as shown by Ank2
reporter line (R54H11-Gal4) expression (Pfeiffer et al., 2008) and
previous studies (Siegenthaler et al., 2015). Reduction, as opposed
to overexpression, of Ank2 also caused a reduction in memory
(Figure 5). Co-expression of human mutant APP (Aβ42) and
MAPT (0N4R Tau; Figure 5) or either AD gene with Ank2-
RNAi caused a similar reduction in memory, suggesting that
all three genes may act in the same pathway in MB neurons.
Overexpression of Ank2, or co-expression of Ank2 with either
human mutant APP (Aβ42) or MAPT (0N4R Tau) did not cause a
significant reduction in memory. The latter cannot be considered
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FIGURE 4 | The effect of expression of human mutant APP (Aβ42), MAPT
(Tau 0N4R) or Drosophila Ank2 on locomotor behavior. The negative
geotaxis-climbing reflex was used to quantify locomotor behavior of 2–5 day
old flies. About 80% of control (elav-Gal4/+) flies were able to climb to the top
of test vial within 10 s; this compared to experimental genotypes expressing
AD transgenes throughout their nervous system. Mis-expression of all AD
associated genes except for overexpression of Ank2 alone, resulted in a
significant reduction in climbing performance using one-way ANOVA with
Dunnett’s multiple comparisons. Error bars are SEM. n ≥ 15 groups of 10 flies.
rescue of the memory deficit caused by expression of Aβ42 or Tau
alone, as the memory of Ank2 co-expressed with either human
mutant APP (Aβ42) or MAPT (0N4R Tau) was not significantly
greater than that of human mutant APP (Aβ42) or MAPT (0N4R
Tau) co-expressed with GFP, again suggesting a Gal4 dilution
effect was contributing to the rescue of the mutant phenotype.
For flies to be able to perform the olfactory shock assay, the fly
must be able to respond normally to shock and the odors used in
the memory task. Therefore, we performed behavioral controls
on 2–5 day old flies that showed that there was no significant
difference between mutant genotypes and wild type in terms of
avoidance of electric shock (Figure 6A), octanol (Figure 6B) and
methylcyclohexanol (MCH; Figure 6C) odors (Cavaliere et al.,
2013; Malik et al., 2013; Malik and Hodge, 2014). Therefore, any
mutant genotype showing a significant reduction in memory in
Figure 5 was a bona fide memory mutant.
Mis-Expression of Human Mutant APP
(Aβ42), MAPT (0N4R Tau), and Ank2
Decreased the Neural Excitability of
Memory Neurons Prior to Any
Observable Neurodegeneration
Changes in neuronal excitability and Ca2+ signaling are thought
to occur early in disease progression prior to neurodegeneration
and are proposed to mediate early changes in behavior in
AD, such as memory loss (Spires-Jones and Hyman, 2014;
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FIGURE 5 | The effect of expression of human mutant APP (Aβ42), MAPT
(Tau 0N4R) and Drosophila Ank2 on memory. One hour memory of 2–5 day
old flies was assessed using the olfactory shock-conditioning assay. The
performance index of flies expressing AD transgenes throughout their
mushroom body (MB) was compared to control (OK107-Gal4/+) and were
found to show a significant reduction in memory using one-way ANOVA with
Dunnett’s multiple comparisons, except genotypes overexpressing Ank2.
Error bars are SEM. n ≥ 4 groups of ∼100 flies.
Wu et al., 2016). Therefore, in order to determine how mis-
expression of human mutant APP (Aβ42), MAPT (0N4R Tau),
and Ank2 may lead to changes in neuronal function and AD
relevant phenotypes, we expressed the genetically encoded Ca2+
reporter, GCaMP6f using the same OK107-Gal4 MB promoter
as for the memory experiments and then measuring peak
intracellular Ca2+ in response to high [K+] solution that non-
specifically depolarizes neurons (Malik et al., 2013). The axons
and synaptic terminals of MB neurons form a pair of bilaterally
arranged and symmetrically lobed structures which show low
basal Ca2+ fluorescence levels (Figure 7A left panel) which,
in response to depolarizing high [K+] saline, show a large peak
in Ca2+ fluorescence levels (Figure 7A right panel). The increase
in neuronal activity can be expressed as the relative fluorescence
change (1F/F0) over time (Figure 7B) showing that high K+
causes a rapid peak Ca2+ influx that returns to baseline after
washing. MB wide overexpression of human mutant APP (Aβ42),
MAPT (0N4R Tau) or mis-expression of Ank2 all caused a similar
decrease in peak Ca2+ influx of memory neurons (Figure 7C),
suggesting a reduction in neuronal excitability. A previous study
showed human 0N4R tau expression in γ MB neurons reduced
learning and 1.5 h memory in 3–5 day old young flies which
were demonstrated to still have their γ neurons intact. However,
by day 45, the 0N4R expressing γ neurons had started to
neurodegenerate (Mershin et al., 2004). In order to verify the
MB were intact in our 2–5 day old flies overexpressing human
mutant APP (Aβ42), MAPT (0N4R Tau) or mis-expressing fly
A
B
C
FIGURE 6 | The effect of expression of human mutant APP (Aβ42), MAPT
(Tau 0N4R) and Drosophila Ank2 on response to negative reinforcement
(shock) and olfaction. (A) The response of 2–5 day old flies to negative
reinforcement was quantified as % avoidance of shock, with experimental
genotypes with AD genes expressed throughout their MB compared to
control (OK107/+). The avoidance of these genotypes of flies to 3-octanol (B)
and methylcyclohexanol (MCH) (C) odors was expressed as a performance
index. All genotypes responded to odors and shock in a manner not
significantly different from wild type using one-way ANOVA with Dunnett’s
multiple comparisons. n ≥ 4 groups of ∼50 flies.
Ank2 throughout the MB we imaged the MB with GCaMP6f
and saw that all the genotypes had intact MB α, β, γ, α′, and β′
lobes (Figure 8).
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A
B
C
FIGURE 7 | The effect of expression of human mutant APP (Aβ42), MAPT
(Tau 0N4R), and Drosophila Ank2 on activation of mushroom body neurons.
(A) Exemplary control 2–5 day old fly MB expressing the calcium reporter
GCaMP6f shows a big increase in relative fluorescence in response to
elevated KCl (100 mM, bath-applied). Images show the same brain before
(left) and during (right) KCl application; scale bar 50 µm. (B) The increase in
neuronal activity is expressed as the relative change in fluorescence (1F/F0)
over time showing that high KCl (indicated by bar) causes peak Ca2+ influx
that returns to baseline after washing. (C) Quantitative analysis of the maximal
response for the indicated genotypes shows a reduced responsiveness of all
mutants. Data was analyzed with one-way ANOVA with Tukey’s post hoc and
error bars are standard deviation, n ≥ 5 brains.
DISCUSSION
In this study, we have characterized the first animal model based
on mis-expression of the AD EWAS nominated ANK1 gene
ortholog in Drosophila. Altered DNA methylation of human
ANK1 occurs in AD brains, especially in regions that show
gross AD pathology, such as the entorhinal cortex (De Jager
et al., 2014; Lunnon et al., 2014). Here, we found reduction
in expression of the fly ortholog of human ANK1, which is
Drosophila Ank2, in areas of the brain responsible for memory
(the MB), caused memory impairment similar in magnitude to
FIGURE 8 | Mushroom body morphology is not affected by expression of
human mutant APP (Aβ42), MAPT (Tau 0N4R), and Drosophila Ank2 in young
flies. Images show representative mushroom bodies of 2–5 day old flies
visualized by expression of the Ca2+ reporter GCaMP6f of (A) a control fly
(OK107/+), (B) OK107 > Tau, (C) OK107 > Aβ42, (D) OK107 > Ank2-RNAi
line A, (E) OK107 > Ank2-RNAi line B, and (F) OK107 > Ank2 which all show
the regular organization of α, β, γ, α′ and β′ lobes. Scale bar is 50 µm.
that caused by overexpression of human mutant APP resulting in
an oligomerizing form of Aβ42 or MAPT producing the 0N4R
isoform of Tau, both of which are particularly associated with
the disease. In flies, overexpression of fly Ank2, did not result
in degeneration of the eye, locomotor or memory defects but
did lead to mild shortening of lifespan (by ∼10%) and reduced
MB excitability.
In addition to memory loss, animals with reduced neuronal
Ank2 also recapitulated the shortening of lifespan seen in those
with AD, again a phenotype seen in flies overexpressing human
mutant APP (Aβ42) or MAPT (0N4R Tau). Co-expression of
human mutant APP (Aβ42) and MAPT (0N4R Tau) caused a
further reduction in lifespan, suggesting that the two molecules
may act in partially non-overlapping and therefore additive
pathways that lead to the pathology causing the flies to die
early. A similar effect on lifespan has been reported previously
for another form of APP that resulted in a non-oligomerizing
version of Aβ42 and another form of MAPT, resulting in
the 1N4R isoform of Tau, however, the longevity assays were
only run for roughly half the lifespan of the flies (Folwell
et al., 2010). We also found a reduction in locomotion in flies
expressing human mutant APP (Aβ42), MAPT (0N4R Tau) and
reduced Ank2. Interestingly, a recent study has shown that ANK1
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hypermethylation is observed in PD, a movement disorder,
that can also be associated with dementia (Smith et al., 2019).
In the eye, overexpression of human mutant APP (Aβ42) or
MAPT (0N4R Tau) were both neurotoxic causing degeneration
of the fly eye photoreceptor neurons. Co-expression caused
a further reduction implying the two act in separate and
additive pathways to cause neurotoxicity and neuronal death.
Reduction in Ank2 did not cause degeneration of the eye
suggesting that Ank2 may affect neuronal function independent
of degeneration. This is likely to be via changes in neuronal
excitability, as we saw when the gene was misexpressed in MB
neurons (Smith and Penzes, 2018). We found misexpression
of human mutant APP (Aβ42), MAPT (0N4R Tau) and
Ank2 all reduced the peak Ca2+ response of MB neurons,
a decrease in excitability likely to contribute to the memory
deficits of these flies.
In Drosophila, Ank2 has been shown to be important for
synaptic plasticity and stability (Koch et al., 2008; Pielage et al.,
2008; Massaro et al., 2009; Keller et al., 2011; Bulat et al.,
2014) and is involved in a glia mediated pathway that causes
degeneration of motor neurons (Keller et al., 2011). Therefore,
it is possible that reduction of Ank2 may only cause degeneration
in certain types of neurons. Furthermore, because human ANK1
has also been shown to be misexpressed in glia in the AD brain
(Mastroeni et al., 2017), it is also possible that neurodegeneration
results from misexpression of Ank2 in glia.
We do not know how Ankyrin interacts with Tau and
what changes in Tau protein level, location or phosphorylation
result from Ankyrin misexpression. We know that Ankyrins
are adaptor proteins that attach to integral membrane proteins
such as the Na+/K+ ATPase, voltage-gated Na+ (Nav1), voltage-
gated K+ (KCNQ) and TrpA1 channels, and then link them
to the actin-spectrin based membrane cytoskeleton, with some
of these molecules having been associated with AD (Bennett
and Baines, 2001; Yamamoto et al., 2007; Smith and Penzes,
2018). Therefore the loss of Ankyrin might be predicted to
disrupt the proper clustering of these ion channels, some
of which are involved in MB-memory and calcium signaling
(Cavaliere et al., 2013), and hence may result in the decreased
neuronal excitability detected by our MB calcium imaging
experiments and which might be required for proper memory
formation. The changes in calcium influx may also cause
dysregulation of calcium dependent phosphorylation of Tau,
also known to disrupt MB dependent memory and shorten
lifespan (Papanikolopoulou and Skoulakis, 2015). Finally, the
loss of Ankyrin may distrupt the actin-spectrin cytoskeleton,
which may result in pathological changes in microtubules
exacerbated by their association with Tau. More experiments
are required to investigate the nature of the interaction between
Ankyrin and Tau in AD.
In summary, we have characterized the first animal model of
a gene implicated in AD that was nominated from EWAS. We
found that mis-expression of the fly ortholog of this gene, Ank2,
in central neurons caused a range of AD-relevant phenotypes
such as shortened lifespan, memory loss, and changes in neuronal
excitability similar to those resulting from human Aβ42 and
0N4R Tau. In alignment with previous AD studies, we conclude
that Ank2 – or, in humans, ANK1 – likely plays a role in
AD neuropathology.
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